Shopping Cart
- Remove All
- Your shopping cart is currently empty
Cetilistat (ATL-962) is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
200 mg | $29 | In Stock |
Description | Cetilistat (ATL-962) is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes. |
Targets&IC50 | Pancreatic lipase (human):5.95 nM, Pancreatic lipase (rat):54.8 nM |
Alias | ATL-962 |
Molecular Weight | 401.58 |
Formula | C25H39NO3 |
Cas No. | 282526-98-1 |
Smiles | O=C1C=2C(N=C(OCCCCCCCCCCCCCCCC)O1)=CC=C(C)C2 |
Relative Density. | 1.02 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | H2O: Insoluble DMSO: Insoluble |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.